Next Article in Journal
Marine Compounds and Cancer: Updates 2022
Next Article in Special Issue
News and Updates from 2022 on Antioxidant and Anti-Inflammatory Properties of Marine Products
Previous Article in Journal
An Efficient and Quick Analytical Method for the Quantification of an Algal Alkaloid Caulerpin Showed In-Vitro Anticancer Activity against Colorectal Cancer
Previous Article in Special Issue
Anti-Inflammatory Effects of Compounds from Echinoderms
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 20
Issue 12
10.3390/md20120758
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Ameliorative Effects of Oyster Protein Hydrolysates on Cadmium-Induced Hepatic Injury in Mice

by
Jingwen Wang
1,2,3,4,†,
Zhijia Fang
1,2,3,4,*,†,
Yongbin Li
1,2,3,4,
Lijun Sun
1,2,3,4,
Ying Liu
1,2,3,4,
Qi Deng
1,2,3,4 and
Saiyi Zhong
1,2,3,4,*
1
College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China
2
Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Zhanjiang 524088, China
3
Guangdong Provincial Engineering Technology Research Center of Marine Food, Zhanjiang 524088, China
4
Key Laboratory of Advanced Processing of Aquatic Products of Guangdong Higher Education Institution, Zhanjiang 524088, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Mar. Drugs 2022, 20(12), 758; https://doi.org/10.3390/md20120758
Submission received: 7 October 2022 / Revised: 25 November 2022 / Accepted: 28 November 2022 / Published: 30 November 2022
(This article belongs to the Special Issue Marine Anti-inflammatory and Antioxidant Agents 2.0)
Browse Figures
Versions Notes

Abstract

:
Cadmium (Cd) is a widespread environmental toxicant that can cause severe hepatic injury. Oyster protein hydrolysates (OPs) have potential effects on preventing liver disease. In this study, thirty mice were randomly divided into five groups: the control, Cd, Cd + ethylenediaminetetraacetic acid (EDTA, 100 mg/kg), and low/high dose of OPs-treatment groups (100 mg/kg or 300 mg/kg). After continuous administration for 7 days, the ameliorative effect of OPs on Cd-induced acute hepatic injury in Cd-exposed mice was assessed. The results showed that OPs significantly improved the liver function profiles (serum ALT, AST, LDH, and ALP) in Cd-exposed mice. Histopathological analysis showed that OPs decreased apoptotic bodies, hemorrhage, lymphocyte accumulation, and inflammatory cell infiltration around central veins. OPs significantly retained the activities of SOD, CAT, and GSH-Px, and decreased the elevated hepatic MDA content in Cd-exposed mice. In addition, OPs exhibited a reductive effect on the inflammatory responses (IL-1β, IL-6, and TNF-α) and inhibitory effects on the expression of inflammation-related proteins (MIP-2 and COX-2) and the ERK/NF-κB signaling pathway. OPs suppressed the development of hepatocyte apoptosis (Bax, caspase-3, and Blc-2) and the activation of the PI3K/AKT signaling pathway in Cd-exposed mice. In conclusion, OPs ameliorated the Cd-induced hepatic injury by inhibiting oxidative damage and inflammatory responses, as well as the development of hepatocyte apoptosis via regulating the ERK/NF-κB and PI3K/AKT-related signaling pathways.

1. Introduction

Cadmium (Cd) is a widespread environmental toxicant that poses a serious threat to human health [1]. Due to its high solubility in water, Cd can easily enter the human body through the food chain from polluted soils and water [2]. Cd exposure will cause metabolic dysfunction and eventually lead to irreversible damage to multiple organs [3,4]. About 50–70% of the absorbed heavy metal accumulates in the kidney and liver [5]. Acute Cd exposure primarily results in liver accumulation and hepatic injury [6]. The liver has been considered one of the main target organs of Cd [7]. Recent research has shown that acute Cd exposure leads to severe hepatic injury, accompanied by oxidative damage, inflammation, and apoptosis [8]. Therefore, reducing oxidative damage, ameliorating inflammatory response, and preventing the development of hepatocyte apoptosis may be practical strategies for the treatment of Cd-induced hepatic injury.
Protein hydrolysates from oysters (Crassostrea hongkongensis) have multiple health benefits, including anti-oxidation [9], anti-inflammatory [10], anti-apoptosis [11], anti-cancer, and other properties [12]. In previous studies, oyster-derived hydrolysates have been shown to be protective against D-galactosamine(D-GalN)-induced hepatic injury [13]. The peptides (SCAP1, SCAP3, and SCAP7) produced from oyster protein hydrolysis (OPs) present strong antioxidant and anti-cancer properties [14]. In addition, OPs are considered to be a safe and effective dietetic treatment for alcoholic liver disease by declining ethanol-induced oxidative stress and inflammation [15]. In addition, oyster ferritin was found to efficiently reduce the damage of heavy metals in mice [16]. The evidence suggests that OPs might be a potential candidate for ameliorating Cd-induced hepatic injury. Therefore, this study aimed to investigate the ameliorative effect of OPs on hepatic oxidative damage, inflammation, and apoptosis in Cd-exposed mice.

2. Results

2.1. Sequence Analysis of the Main Peptides of OPs

As shown in Figure 1, the peaks of OPs were mostly in the range of 300 to 900 m/z. Overall, 177 peptides, with molecular weights ranging from 550.250 to 1387.697 Da, and an intensity ranging from 3,857,400 to 171,200,000, were identified from the OPs. The peptide fingerprinting of 40 characteristic peptides in OPs was analyzed using liquid chromatography–tandem mass spectrometry (LC-MS/MS). The scores for evaluating the matches between the theoretical and experimental mass spectrums were obtained by comparing the UniProt database; 20 peptide sequences with higher scores are listed in Table 1. Of interest, they contain a higher percentage of hydrophobic amino acids, such as proline (P, 37/180 residues in 20 peptides), valine (V, 14/180), and alanine (A, 8/180). Specific amino acid motifs, such as PVX, was repeated six times, and PxxP was repeated eight times, X being either a glycine, serine, or a proline residue, x being either an alanine, glycine, valine, threonine, asparagine, leucine, glutamic acid, aspartic acid, or an arginine, can be recognized. Hydrophobic amino acids proline or proline-rich peptides were reported to possess good anti-Cd, anti-oxidation, and anti-inflammatory properties [17,18,19,20,21,22].

2.2. Composition of Amino Acid in OPs

According to the data from the automatic analyzer, the content of total amino acids in OPs was 33.73 g/100 g (Table 2). The content of essential amino acids in OPs was 11.82 g/100 g and accounted for 35.04% of the total amino acids. The content of hydrophobic amino acids was 12.76 g/100 g and accounted for 37.83% of the total amino acids. OPs were rich in Glutamic acid (Glu, 4.33 g/100 g), Aspartic acid (Asp, 3.36 g/100 g), Alanine (Ala, 2.63 g/100 g), Proline (Pro, 2.61 g/100 g), and Lysine (Lys, 2.61 g/100 g).

2.3. Contents of Free Amino Acids in OPs

Table 3 shows the free amino acid content and composition of OPs. The contents of total free amino acids in OPs were 15.80 g/100 g, indicating OPs contained abundant free amino acids. Among these free amino acids, Pro (2.49 g/100 g), Glu (2.12 g/100 g), Tyr (1.51 g/100 g), Lys (1.43 g/100 g), Gly (1.38 g/100 g), and Val (0.91 g/100 g) were highly detected in OPs. The essential free amino acids accounted for 33.73% of the free total amino acids, and free hydrophobic amino acids accounted for 38.86%.

2.4. Effects of OPs on Hepatic Dysfunction in Cd-Exposed Mice

Compared with the control group, the Cd-exposed mice group showed the highest levels of serum alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) (Figure 2). EDTA therapy is the most widely used for treating patients with acute or chronic Cd disease [23]. Thus, it was used as a positive control in this test. The supplement of OPs significantly decreased the levels of serum ALT, AST, ALP, and LDH (p < 0.01). The effects of OPs were met even better than that of the positive agent EDTA treatment. OPs exhibited a good ameliorative effect on hepatic dysfunction in Cd-exposed mice.

2.5. Effect of OPs on Hepatic Injury in Cd-Exposed Mice

The organ weight coefficient is commonly used to evaluate the toxic effect [24]. The liver weight coefficient of the mice in the Cd-exposed group was significantly higher than that of the mice in the control group (p < 0.01). The OPs markedly lowered the liver coefficients in Cd-exposed mice (p < 0.01). Histopathological sections of the liver stained with H&E are shown in Figure 3B. Compared with the control group, the mice in the Cd group showed obvious pathological changes in liver tissue, including apoptotic bodies, hemorrhage, lymphocyte accumulation, and inflammatory cell infiltration around the central vein. In the OPs and EDTA-treated groups, liver tissue retained its normal appearance and had fewer apoptotic bodies. OPs showed a protective effect on liver tissue against Cd.

2.6. Effect of OPs on Hepatic Oxidative Indexes in Cd-Exposed Mice

An increased MDA level is an important indicator of oxidative stress. The Cd-exposed mice group showed the highest levels of hepatic MDA, while the OPs treatment significantly lowered the level of MDA (p < 0.01, Figure 4A). More importantly, the effects of OPs were better than that of EDTA. OPs markedly inhibited lipid peroxidation (MDA as an indicator) and MDA production in Cd-exposed mice. As shown in Figure 4B–D, antioxidant markers such as SOD, CAT, and GSH-Px were significantly reduced in the Cd-exposed mice group compared to the control group. OPs retained higher activity of antioxidant enzymes in Cd-exposed mice. OPs exhibited a strong reductive effect on Cd-induced oxidative stress in the liver.

2.7. Effect of OPs on The Hepatic Inflammatory Response (IL-1β, IL-6, TNF-α) in Cd-Exposed Mice

Interleukin IL-1β and IL-6 are two stimulators of the hepatic synthesis of acute-phase proteins in the inflammatory response to stress and important biological markers of hepatic inflammation [25,26]. TNF-α is an important biological marker in substantial hepatic tissue damage [27]. As shown in Figure 5A–C, the mice in the Cd-exposed group have the highest level of hepatic inflammatory cytokines (IL-1β, IL-6, and TNF-α) (p < 0.01). OPs significantly attenuated Cd-induced the high level of hepatic IL-1β, IL-6, and TNF-α (p < 0.01 and p < 0.05, respectively). The results from quantitative reverse-transcription PCR analysis (qRT-PCR) manifested that OPs inhibited the expression of hepatic IL-1β, IL-6, and TNF-α in Cd-exposed mice (p < 0.01). These results revealed that the protection of OPs against Cd was associated with its attenuation of the Cd-induced hepatic inflammation in Cd-exposed mice.

2.8. Effect of OPs on The Expression of Hepatic COX-2, MIP-2, NF-κB, and p-ERK in Cd-Exposed Mice

COX-2 is a key enzyme in initiating hepatic inflammatory reactions [28]. Meanwhile, macrophage inflammatory protein (MIP)-2 is a potent neutrophil attractant and activator, contributing to the pathogenesis of inflammatory diseases [29]. MIP-2 and COX-2 would be elevated in Cd-induced inflammation [30]. As shown in Figure 6A, enhanced COX-2 and MIP-2 staining were observed around the central vein of hepatocytes in the Cd-exposed group. OPs treatment noticeably reduced the hepatic COX-2 and MIP-2 levels.
In the process of Cd-induced inflammation, the extracellular signal-regulated kinase (ERK) signal pathway would be activated, and the nuclear factor-κB (NF-κB) subsequently was up-regulated [31]. Western blotting assays illustrated that the expression of NF-κB and p-ERK were highly induced in the Cd-exposed group. However, the OPs treatment effectively dampened the expression of NF-κB and p-ERK (p < 0.01; Figure 6B,C). The above results implied that OPs might alleviate hepatic inflammation by inhibiting the expression of inflammatory activators (COX-2 and MIP-2) and related inflammatory pathways (NF-κB and ERK).

2.9. Effect of OPs on Hepatic Apoptosis in Cd-Exposed Mice

Apoptosis-related mitochondrial Bcl2-associated X protein (Bax) and Caspase-3 are two important pro-apoptotic factors. Under the stimulation of oxidative stress caused by Cd, the hepatic Bax increased, then the downstream Caspase-3 was up-regulated, and eventually, apoptosis occurred [32]. Anti-apoptotic Bcl-2 plays a central regulatory role in apoptosis [33]. Accordingly, we examined the effect of OPs on Cd-induced hepatic apoptosis by measuring the levels of pro-apoptotic factors (Bax and caspase-3) and anti-apoptotic factor Bcl-2 in Cd-exposed mice. As shown in Figure 7A–C, Cd significantly decreased the levels of anti-apoptotic Bcl-2 but increased the levels of pro-apoptotic factors (Bax and caspase-3) (p < 0.01). On the contrary, OPs treatment significantly increased Bcl-2 while decreasing Bax and caspase-3 levels in Cd-exposed mice (p < 0.01). The qRT-PCR results showed that OPs significantly induced the expression of Bcl-2 while suppressing the expression of Bax and caspase-3 in Cd-exposed mice (p < 0.01). OPs exhibited a strong anti-apoptotic effect on Cd-induced apoptosis in mice.
Cd can regulate the PI3K/AKT signaling pathway to induce apoptosis [34,35]. Additionally, PI3K/AKT signaling pathway also plays a crucial role in the regulation of inflammatory protein expressions (COX-2 and MIP-2) [36]. Western blotting assays demonstrated that Cd exposure led to the elevation of the expression of PI3K and p-AKT, accompanied by the imbalance of pro-/anti-apoptotic proteins (Bax, caspase-3 and Bcl-2) (p < 0.05). By contrast, the OPs treatment inhibited the activation of the PI3K/AKT signaling pathway and restored the balance of pro-/anti-apoptotic proteins in Cd-exposed mice. The results implied that OPs might alleviate hepatic apoptosis by restoring the balance of pro-/anti-apoptotic proteins via inhibiting the PI3K/AKT signaling pathway in Cd-exposed mice.

3. Discussion

As one of the main target organs of Cd, acute hepatic injury was observed in Cd-exposed mice. Fortunately, the OPs treatment clearly ameliorated the Cd-induced hepatic injury in this study. In particular, oxidative damage, inflammation, and cell apoptosis, as crucial triggers and contributors to the development of Cd-induced hepatic injury [30,34,35,37], were improved after OPs application in Cd-exposed mice.
Extensive literature indicates that the health benefits of protein hydrolysates may be partly attributed to their rich in free amino acids and peptides [38,39]. Extracts rich in free amino acids can be used in pharmaceutical applications [40]. A recent study found that free amino acids were related to the antioxidant property of protein hydrolysates of mackerel [38]. The protein hydrolysates with higher contents of free amino acids exhibited better antioxidant properties [41] and metal-chelating ability [42]. In the present study, a high level of free amino acids (15.8%) was detected in OPs. According to a previous report, the royal jelly hydrolysates with 8.389% of free amino acids had a stronger antioxidant activity than those of royal jelly with 0.572% of free amino acids [43]. A similar study also found the anchovy sprat hydrolysates with higher contents of free amino acids (16.28–27.53%) exhibited stronger ferrous-chelating activity and radical-scavenging activity compared to those with lower contents of free amino acids (9.05%) [44]. These data indicated that OPs were rich in free amino acids, which may contribute to the potential health benefits of OPs against Cd toxicity.
Serum ALT and AST are leaked from damaged hepatocytes [45,46]. Cd intoxication led to a significant elevation in the levels of ALT and AST [47]. In the present study, significant improvements were observed in the hepatic injury and dysfunction biomarkers (serum AST, ALT, ALP, and LDH) in Cd-exposed mice after the OPs treatment. Compared to the Cd group, OPs significantly decreased hepatic dysfunction biomarkers in a dose-dependent manner. This result is in line with an earlier report, in which oyster protein hydrolysate could reduce hepatic dysfunction biomarkers (serum AST, ALT, and ALP) and inflammatory response in alcoholic liver disease mice [48]. Likewise, Shi, Sun [49] reported that ganoderma lucidum peptides have an alleviative effect on D-GalN-induced hepatocellular injury via reversing AST and ALT levels in the liver. Moreover, Mumtaz, Ali [50] found that elevated level of LDH, AST, and ALT in the Cd-exposed batch was improved by ascorbic acid. Early evidence indicates that hepatic injury and cirrhosis usually lead to metabolic disturbances of amino acids [51]. The bioactive properties of protein hydrolysates mainly depend on free amino acids and peptides [38,39,52]. The present study showed that OPs are rich in hydrophobic free amino acids (i.e., Pro) and proline-rich peptides. Among these amino acids, Pro plays a beneficial role in plants under changing environments, including Cd stress [53]. Exogenous Pro could increase antioxidant enzyme activities and confer tolerance to cadmium stress in cultured tobacco cells [22]. Pro has shown tissue-protective effects against D-galactosamine-induced hepatic injury [54]. Dietary Pro could effectively decrease AST and ALT levels of shrimp under NH3 stress [55]. The derivatives of Pro, N-acetyl-seryl-aspartyl-lysyl-proline, were found to attenuate bile duct ligation-induced liver fibrosis by restoring hepatic dysfunction (serum AST and ALT) in mice [56]. Pro and proline-rich proteins are often implicated in stress tolerance in plants [57,58,59]. Salivary proline-rich proteins possess good antioxidant properties [60]. Hypothalamic proline-rich polypeptides were found to protect brain neurons in aluminum neurotoxicosis [61]. These data support the idea that OPs could ameliorate hepatic injury and improve hepatic dysfunction in Cd-exposed mice.
Oxidative stress is often implicated in the induction of multi-organ injury under Cd exposure [62]. Lipid peroxidation is a major consequence of Cd-induced oxidative stress [63]. The consequences of the peroxidative of membrane lipids have been considered in relation to the tissue aspects of liver injury, and these peroxidative reactions play a critical role in the pathogenesis of acute liver necrosis [64]. According to a previous report, the liver, kidneys, and heart were most susceptible to Cd-induced oxidative stress in mice [65]. Some amino acid derivatives, such as N-Acetylcysteine, showed ameliorative effects on cisplatin-induced multiple organ toxicity in rats [66,67,68]. Betulinic acid was found to alleviate the kidney and liver damage induced by Cd [69]. In this study, Cd exposure induced serious hepatic toxicity and oxidative stress, which were significantly improved after the OPs supplement. These data suggest that amelioration of hepatic oxidative injury may be the key to the treatment of Cd toxicity by OPs in mice.
Oxidative stress plays a crucial role in Cd-induced hepatic toxicity [70]. The development of liver injury usually involves the lipid peroxidation of hepatic cell membranes in Cd-exposed mice [71]. According to a recent report, Cd-induced hepatic injury is tightly coupled with enhanced lipid peroxidation (MDA) and the significant depletion of antioxidants (CAT and SOD) [72]. In this study, the OPs supplement clearly reduced the formation of MDA and significantly restored the activity of antioxidant enzymes (SOD, CAT, and GPH-Px) in the liver of the Cd-exposed mice. OPs displayed a strong antioxidant activity, which might also be attributed to their abundance of hydrophobic amino acids. Commonly, protein hydrolysates with higher content of hydrophobic amino acids possess better antioxidant properties due to their more effective interaction with lipid-soluble free radicals and the prevention of lipid peroxidation [17,73,74,75]. Thus, this evidence clearly indicated that OPs possess good antioxidant properties to delay hepatic oxidative injury via retaining hepatic antioxidant enzymes and preventing MDA production in Cd-exposed mice.
Hepatic histopathological damage in Cd-exposed mice is characterized by apoptotic bodies, hemorrhage, lymphocyte accumulation, and inflammatory cell infiltration in liver tissue. Increasing evidence demonstrates that hepatic injury and fibrosis are accompanied by the elevation of the inflammatory response [76]. As well known, TNF-α and IL-6 are two key inflammatory mediators of tissue injury-induced inflammatory response [77]. IL-1β and IL-6 are two stimulators of the hepatic synthesis of acute-phase proteins in the inflammatory response to stress [25,26]. Cd exposure will trigger an acute inflammatory response in mice [78]. The present study showed that hepatic apoptotic cells in Cd-exposed mice were significantly minimized, and histopathological appearance was obviously improved after OPs treatment. In addition, the Cd-triggered inflammatory responses (IL-1β, IL-6, and TNF-α) were significantly inhibited, as expected. This result is consistent with the findings in an earlier report, in which peptides from oyster soft tissue hydrolysates selectively repressed TNF-α, IL-1β, and IL-6 [79]. To go even further, we found that as important activators and regulators of inflammatory responses, MIP-2 [29], COX-2 [28], NF-κB, and the ERK signal pathway [80], were significantly stimulated in Cd-exposed mice. The results are in agreement with a previous study, in which Cd activated the ERK signal pathway, then subsequently up-regulated TNF-α, COX-2, IL-1β, IL-6, and NF-κB in swine [31]. Likewise, Huang, Xia [30] reported that Cd exposure led to an increase in MIP-2 and COX-2. Actually, ROS production could activate MAPK signaling to induce inflammation and skin aging by promoting the phosphorylation of ERK [32]. Peng, Chen [81] also found that the up-regulated ERK phosphorylation in ultraviolet B-exposed mice was significantly inhibited by the application of oyster protein hydrolysates. A recent study found that seahorse protein hydrolysates could significantly inhibit p-ERK levels in ethanol-exposed cells. [82]. In this study, Western blotting assays showed that OPs significantly decreased the levels of p-ERK and NF-κB proteins, as well as the MIP-2 and COX-2 in Cd-exposed mice. Therefore, the ameliorative effect of OPs in Cd-caused liver injury may be related to its anti-inflammation properties via suppressing the production of inflammatory mediators and inhibiting the inflammatory response associated with NF-κB and the ERK signal pathway.
In addition to inflammatory responses, hepatic injury is also accompanied by the development of apoptosis in Cd-exposed mice. Reducing Cd-induced apoptosis is also considered to be one of the feasible ways to prevent Cd-induced hepatic injury [69]. In the process, the NF-κB inflammation pathway indirectly activated the apoptosis-related factors Bcl-2, Bax, and Caspase-3 [31]. The present study revealed that the OPs supplement strongly up-regulated the expression of the anti-apoptotic factor Bcl-2 while significantly down-regulated the expression of the pro-apoptotic factors (caspase-3 and Bax), eventually restoring the balance of pro-/anti-apoptotic proteins in Cd-exposed mice. Moreover, the PI3K/AKT pathway is an important signaling pathway associated with apoptosis [83]. Actually, Cd selectively induces MIP-2 and COX-2 through the activation of the PI3K/AKT [30]. A previous study showed that curcumin alleviated lipopolysaccharide-induced hepatic injury and apoptosis via inhibiting the PI3K/AKT and NF-κB pathways [84]. MiR-130a alleviated neuronal apoptosis and changes in the expression of Bcl-2/Bax and caspase-3 in cerebral infarction rats through the PI3K/AKT signaling pathway [85]. In the present study, we found that the OPs supplement significantly inhibited the expression of PI3K and p-AKT proteins. These results are in agreement with an earlier report, in which Selenomethionine ameliorated Cd-induced hepatocyte apoptosis by suppressing the PI3K/AKT pathway [86]. Therefore, we may conclude that OPs possess the ability to ameliorate hepatocyte apoptosis, possibly by restoring the balance of pro-/anti-apoptotic proteins via suppressing the PI3K/ AKT pathway in Cd-exposed mice.
In conclusion, from our study, we found that OPs could effectively ameliorate Cd-induced hepatic injury through their antioxidative and anti-inflammatory properties. In addition, OPs displayed an important role in restoring the balance between pro-apoptotic and anti-apoptotic proteins by suppressing the activation of the PI3K/AKT pathway, contributing to the development of hepatocyte apoptosis in Cd-exposed mice (Figure 8). These results may provide a new insight for a better understanding of the ameliorative function of OPs to Cd toxicity and provide a theoretical basis for the use of OPs to prevent or treat Cd-induced hepatic injury.

4. Materials and Methods

4.1. Chemical and Materials

Cadmium chloride (CdCl2) was purchased from West Long Chemical (Shantou, Guangdong, China). Fresh oysters (Crassostrea hongkongensis) were purchased from the local market in Zhanjiang, China. The kits for measurement of ALT (C009-2-1), AST (C010-2-1), ALP (A059-2-2), and LDH (A020-2-2) were offered by Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The kits used to measure the levels of SOD (BC0170), GSH-Px (BC1195), CAT (BC0205), and MDA (BC0025) were purchased from Solarbio Science & Technology (Beijing, China), and the other chemicals were purchased from Sangon Biotech (Shanghai, China) unless specifically noted otherwise.

4.2. Animals and Experimental Design

Thirty Specific-Pathogen-Free (SPF) mice (Kunming mice, 25–35 g) were obtained from Changsha Tianqin Biotechnology Co., Ltd. (Changsha, China), and the animals were maintained at the Guangdong Ocean University Animal Centre under light (12 h of light and dark) and temperature (~25 °C). The animals were given a standard laboratory diet and water. The experiment was approved by the Animal Ethics Committee of Guangdong Ocean University (No.: GDOU-LAE-2020-009). The animals were randomly divided into 5 groups (n = 6). Control group: Intraperitoneal injection of 0.9% NaCl (saline) once daily. Cd-exposed group: the mice were injected intraperitoneally with CdCl2 5 mg/kg daily [87]. EDTA-treated group (positive control): the mice were injected with CdCl2 (5 mg/kg) intraperitoneally after 1 h of oral administration with EDTA (100 mg/kg) daily. The low dose of OPs(L-OPs)-treated group: the mice were injected with CdCl2 (5 mg/kg) intraperitoneally after 1 h of oral administration with OPs (100 mg/kg) daily. High dose of OPs (H-OPs)-treated group: the mice were injected with CdCl2 (5 mg/kg) intraperitoneally after 1 h of oral administration with OPs (300 mg/kg) daily. It has been shown that ethylenediaminetetraacetic acid (EDTA) can alleviate cadmium toxicity by enhancing antioxidant enzyme activity and inhibiting inflammatory responses [88]. Therefore, it can be used as a positive control. The doses of EDTA and OPs were determined based on previous studies [89,90]. After 7 days, the mice were executed by cervical dislocation, and the liver was stored at −80 °C for further analysis.

4.3. Preparation of OPs

OPs were prepared by enzymatic hydrolysis from the oyster (Crassostrea hongkongensis) meat as described previously [81,90]. Hong Kong oyster meat (~3 kg) was homogenized in distilled water (1:3 (w/w) at 8000 rpm for 5 min. Homogenized oysters were hydrolysed using neutral protease (2 × 105 U/g, Pangbo Biotech, Nanning, China) at a protease/substrate ratio of 2.0% (w/v) (pH 7.0). The neutral protease was incubated for 4 h at 50 °C and then inactivated at 100 °C for 15 min. The hydrolysate was centrifuged at 15,000 rpm for 20 min at 4 °C to obtain the supernatant. The supernatant was collected and ultrafiltered using a membrane bioreactor system with a molecular mass cut-off value of 3 kDa to collect the fractions (<3 kDa). The samples were collected and freeze-dried for further analysis.

4.4. Peptide Sequence Analysis Based on LC-MS/MS

The peptide sequence analysis used an Easy-nLC 1200 system coupled to a Q-Exactive quadrupole-Orbitrap mass spectrometry (Thermo Fisher Scientific, San Jose, CA, USA). One μL of the samples was injected with an autosampler into an Acclaim Pep Map RPLC C18 column (150 μm i.d. × 150 mm, C18, particle size: 1.9 μm, pore size: 100 Å, Dr. Maisch GmbH, Darmstadt, Hessen, Germany) with mobile phase A: 0.1% formic acid in water; B: 0.1% formic acid in the water, 80% acetonitrile. The flow rate was 600 nL/min, and the LC linear gradient ranged from 4% to 40% for 55 minutes and 10 minutes at 95% mobile phase B. Finally, the molecular mass, sequence, peak area (with respect to base peak), and relative peak area (peak area/total peak area) of the peptides were identified and calculated as previously described [81,91]. The conditions of the mass spectrometer were as follows: Resolution: 70,000, AGC target: 3e6, NCE/stepped NCE: 28. The samples were analyzed with a full-scan MS mode in the range of 100–1500 m/z to obtain the total ion chromatogram. The raw MS files were analyzed and searched against the target protein database based on the species of the samples using Byonic.

4.5. LC-MS/MS Analysis of Free Amino Acids

The amino acid composition and content of the OPs were measured, as previously described, with little modification [92]. The OPs samples were accurately weighed to 50 mg and mixed with 600 μL of a water–methanol solution (1:1, v/v) with 10% formic acid in a 2 mL tube. Then, 100 mg of glass beads were added to the mixed samples and vortexed for 30 s. The samples were transferred to a high-throughput tissue grinding machine (MB-96, Meibi, Jiaxing, Zhejiang, China) and vibrated at 60 Hz for 2 min. The tube was centrifuged at 12,000 rpm for 5 min at 4 °C. Ten μL of supernatant was transferred to a new tube containing 490 μL of the water–methanol solution (1:1, v/v) with 10% formic acid and then vortexed for 30 s. Then, 100 μL of the diluted samples were mixed with 100 μL of 100 μg/L double isotope internal standard (Trp-d3, D87103, Medical Isotopes, USA) and vortexed for 30 s. The mixed samples were filtered through a 0.22 μm hydrophilic PTFE filter and transferred into a labeled vial, and subsequently analyzed via LC–MS/MS.
Five μL of the samples were injected into an ACQUITY UPLC BEH C18 column (2.1 × 100 mm,1.7 μm, Waters, Milford, MD, USA) with mobile phase A: 10% water -methanol solution with 0.1% formic acid; B: 50% water-methanol solution with 0.1% formic acid. The flow rate: 300 μL/min in 8.5 min, then kept 300–400 μL/min for 4 min. The gradient elution programs: 0~6.5 min, 10~30% B; 6.5~7 min, 30~100% B; 7~8 min, 100% B; 8~8.5 min, 100~10% B; 8.5~12.5 min, 10% B.
Mass spectrometric analysis was performed using an AB SCIEX AB4000 Mass Spectrometer (AB SCIEX, Framingham, MD, USA) equipped with an electrospray ionization (ESI) source using the following parameters: capillary voltage: 5500 V, temperature of the turbo heaters: 500 °C, nebulizer gas (GS1): 50 psi, auxiliary gas (GS2): 50 psi, and curtain gas (CUR): 30 psi, Collision Gas: 6 psi. All of the amino acids were detected in the multiple reaction monitoring mode (MRM).

4.6. Analysis of Amino Acid Composition

According to the previous method with a slight modification [81]. Approximately 30 mg of the sample and 10 mL of 6 mol/L HCl were added to a hydrolysis tube containing phenol. After the tube was vacuumed, the mixture was washed with nitrogen and hydrolyzed at 110 °C for 22 h. After cooling to room temperature, the filtrate is filtered and spun dry under reduced pressure in a centrifuge tube. The 0.02 mol/L HCl solution was added to a dried centrifuge tube and dissolved, and the solution was transferred to the upper sample bottle and determined using an amino acid analyzer (L-8900, Hitachi, Tokyo, Japan). Then, the contents of amino acids in the sample could be determined according to the peak area in comparison with the standard. The content of tryptophan in OP was determined after hydrolysis with 6 mol/L of NaOH instead of HCl.

4.7. Histopathology Examination

The liver samples were fixed in 4% paraformaldehyde for 24 hours and embedded in paraffin. The embedded liver tissue was sectioned into 5 µm sections and fixed on slides, stained with hematoxylin and eosin (H&E) and observed under a BX 53 Olympus microscope according to the method described [93].

4.8. Analysis of Liver Function

The blood samples were collected as previously described [94,95]. Blood samples were gained by removing the eyeballs of mice. Blood was then centrifuged at 4000 rpm for 30 min at 4 °C. The samples were incubated in an electro-thermostatic water bath at 37 °C for 30 min. The serum was collected and subjected to the examination of the activities of alanine transaminase (ALT), aspartate aminotransferase (AST) activities, the activities of lactate dehydrogenase (LDH), and alkaline phosphatase (ALP) with respective commercial kits. The determination of AST, ALT, LDH, and ALP was performed by the instruction of the kits (Nanjing Jianchen Bioengineering Institute, Nanjing, China).

4.9. Measurement of MDA, SOD, CAT and GSH-Px Activities

The changes in hepatic oxidative stress were monitored as previously described [65]. The liver homogenate was centrifuged to obtain the supernatant at 3500 rpm for 10 min at 4 °C, and the superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) activity, and malondialdehyde (MDA) levels were measured according to the manufacturer’s instructions.

4.10. Measurement of IL-1β, IL-6 and TNF-α in Hepatic Tissue by ELISA Kits

The concentrations of IL-1β (MM-0905M1), IL-6 (MM-1011M1), and TNF-α (MM-0679M1) were measured using an ELISA kit (MeiMian, Yancheng, Jiangsu, China) according to the manufacturer’s instructions.

4.11. Immunohistochemistry Analysis

MIP-2 and COX-2 expressions in hepatic tissue were evaluated by immunohistochemistry staining as previously described [96]. The prepared hepatic sections were recovered, and the endogenous peroxidase in tissues was inactivated with 0.1% hydrogen peroxide containing methanol for 15 min. Then, the sections were incubated with a rabbit polyclonal MIP-2 and COX-2 antibody at 4 °C overnight. Subsequently, the sections were washed with PBS and incubated with rabbit anti-mouse (1:1000) secondary antibody at room temperature for 30 min. The sections were rinsed with PBS 3 times and stained with diaminobenzidine (DAB). Additionally, they were evaluated under an optical microscope (Olympus Optical Co., Ltd., Tokyo, Japan).

4.12. Measurement of Bax, Caspase-3 and Bcl-2 in Hepatic Tissue

The levels of pro-apoptotic-related protein Bax (MM-1143H2) and anti-apoptotic-related protein Bcl-2 (MM-0306M2) were performed using an ELISA kit (MeiMian, Yancheng, Jiangsu, China) according to the manufacturer’s instructions. Caspase-3 activity was measured using a kit (C1115) purchased from Beyotime Biotechnology (Shanghai, China).

4.13. Quantitative Reverse-Transcription PCR (qRT-PCR) Analyses

The total RNA from each sample was isolated using the Trizol reagent (Sango Shanghai, China), and the first strand cDNA was synthesized using the StarScript II First-strand cDNA Synthesis Mix With gDNA Remover (Genstar) according to the manufacturer’s instructions. Quantitative reverse-transcription PCR (qRT-PCR) was conducted to determine the mRNA levels of the IL-1β, IL-6, TNF-α, Bax, Caspase-3, and Bcl-2 (the primer sequences are shown in Table 4), the GAPDH gene was used as an internal control [8,30,97]. Real-time PCR reactions were performed on a CFX Real-time system (CFX96, Bio-Rad, Hercules, CA, USA). All of the samples were analyzed in triplicate, and the 2−ΔΔCt method was used to analyze gene expression levels.

4.14. Western Blotting Analyses

The hepatic tissues were lysed with RIPA lysis buffer (Servicebio technology, Wuhan, China), supplemented with protease inhibitor (Servicebio), and homogenized with an ultrasonic processor. According to the manufacturer’s instructions, the total protein of the liver tissue was extracted with a commercial kit (Servicebio technology, Wuhan, China). Then, the concentration of the protein was measured with a BCA kit (Beyotime technology, Shanghai, China). Then, the proteins were transferred to a polyvinylidene fluoride (PVDF) membrane, followed by blocking with 5% skim milk (0.5% TBST) and sealed for 1 h. Additionally, then, PDVF membranes were incubated with primary antibodies against NF-κB (1:1000), p-ERK (1:1000), PI3K (1:1000), p-AKT (1:1000), Caspase-3 (1:1000), Bcl-2 (1:1000), Bax (1:1000), and GAPDH (1:3000) were incubated overnight at 4 °C. They were washed with TBST at room temperature on a decolorizing shaker three times. After washing, PVDF membranes were incubated with secondary antibodies (1:3000) at room temperature for 2 h. The antibodies were purchased from Proteintech Group, USA. Finally, they were developed and fixed with developing and fixing reagents, and the Alpha software processing system analyzes the optical density values of the target band.

4.15. Statistical Analysis

The data are expressed as the mean ± SE. Data analyses were carried out using JMP Pro 13. The data were analyzed using general descriptive statistics. One-way analysis of variance (ANOVA) at 95%. p < 0.05 was considered statistically significant.

Author Contributions

Conceptualization, J.W. and Y.L. (Ying Liu); methodology, J.W.; validation, L.S., Y.L. (Ying Liu), S.Z. and Q.D.; formal analysis, S.Z. and Y.L. (Yongbin Li); investigation, Z.F. and Q.D.; resources, Z.F.; data curation, J.W., Y.L. (Ying Liu) and Z.F.; writing—original draft preparation, J.W.; writing—review and editing, Z.F.; visualization, L.S., Y.L. (Yongbin Li), S.Z. and Q.D.; funding acquisition, Z.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (No. 32172215 and 31701706). The Program for Scientific Research Start-up Funds of the Guangdong Ocean University (No. R17102), Characteristic Innovation Project of Guangdong Province (No. 2018KTSCX089) and Guangdong Basic and Applied Basic Research Foundation (No. 2019A1515010809, 2021A1515012443). The Innovative Team Program of High Education of Guangdong Province (2021KCXTD021).

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jaishankar, M.; Tseten, T.; Anbalagan, N.; Mathew, B.B.; Beeregowda, K.N. Toxicity, mechanism and health effects of some heavy metals. Interdiscip. Toxicol. 2014, 7, 60–72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Jomova, K.; Valko, M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283, 65–87. [Google Scholar] [CrossRef] [PubMed]
  3. Abdeen, A.; Abou-Zaid, O.A.; Abdel-Maksoud, H.A.; Aboubakr, M.; Abdelkader, A.; Abdelnaby, A.; Abo-Ahmed, A.I.; El-Mleeh, A.; Mostafa, O.; Abdel-Daim, M.; et al. Cadmium overload modulates piroxicam-regulated oxidative damage and apoptotic pathways. Env. Sci. Pollut. Res. Int. 2019, 26, 25167–25177. [Google Scholar] [CrossRef] [PubMed]
  4. Zhang, J.; Wang, Y.; Fu, L.; Wang, B.; Ji, Y.L.; Wang, H.; Xu, D.X. Chronic cadmium exposure induced hepatic cellular stress and inflammation in aged female mice. J. Appl. Toxicol. 2019, 39, 498–509. [Google Scholar] [CrossRef] [PubMed]
  5. Nawrot, T.S.; Staessen, J.A.; Roels, H.A.; Munters, E.; Cuypers, A.; Richart, T.; Ruttens, A.; Smeets, K.; Clijsters, H.; Vangronsveld, J. Cadmium exposure in the population: From health risks to strategies of prevention. BioMetals 2010, 23, 769–782. [Google Scholar] [CrossRef] [Green Version]
  6. Arroyo, V.; Flores, K.; Ortiz, L.; Gómez-Quiroz, L.; Gutiérrez-Ruiz, M. Liver and Cadmium Toxicity. J. Drug Metab. Toxicol. 2012, 5, 1–7. [Google Scholar]
  7. Andjelkovic, M.; Buha Djordjevic, A.; Antonijevic, E.; Antonijevic, B.; Stanic, M.; Kotur-Stevuljevic, J.; Spasojevic-Kalimanovska, V.; Jovanovic, M.; Boricic, N.; Wallace, D.; et al. Toxic Effect of Acute Cadmium and Lead Exposure in Rat Blood, Liver, and Kidney. Int. J. Env. Res. Public Health 2019, 16, 274. [Google Scholar] [CrossRef] [Green Version]
  8. Almeer, R.S.; Alarifi, S.; Alkahtani, S.; Ibrahim, S.R.; Ali, D.; Moneim, A. The potential hepatoprotective effect of royal jelly against cadmium chloride-induced hepatotoxicity in mice is mediated by suppression of oxidative stress and upregulation of Nrf2 expression. Biomed. Pharm. 2018, 106, 1490–1498. [Google Scholar] [CrossRef]
  9. Miao, J.; Liao, W.; Kang, M.; Jia, Y.; Wang, Q.; Duan, S.; Xiao, S.; Cao, Y.; Ji, H. Anti-fatigue and anti-oxidant activities of oyster (Ostrea rivularis) hydrolysate prepared by compound protease. Food Funct. 2018, 9, 6577–6585. [Google Scholar] [CrossRef]
  10. Chalamaiah, M.; Yu, W.; Wu, J. Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: A review. Food Chem. 2018, 245, 205–222. [Google Scholar] [CrossRef]
  11. Fuda, H.; Watanabe, M.; Hui, S.P.; Joko, S.; Okabe, H.; Jin, S.; Takeda, S.; Miki, E.; Watanabe, T.; Chiba, H. Anti-apoptotic effects of novel phenolic antioxidant isolated from the Pacific oyster (Crassostrea gigas) on cultured human hepatocytes under oxidative stress. Food Chem. 2015, 176, 226–233. [Google Scholar] [CrossRef] [PubMed]
  12. Umayaparvathi, S.; Arumugam, M.; Meenakshi, S.; Dräger, G.; Kirschning, A.; Balasubramanian, T. Purification and Characterization of Antioxidant Peptides from Oyster (Saccostrea cucullata) Hydrolysate and the Anticancer Activity of Hydrolysate on Human Colon Cancer Cell Lines. Int. J. Pept. Res. Ther. 2013, 20, 231–243. [Google Scholar] [CrossRef]
  13. Siregar, A.S.; Nyiramana, M.M.; Kim, E.J.; Cho, S.B.; Woo, M.S.; Lee, D.K.; Hong, S.G.; Han, J.; Kang, S.S.; Kim, D.R.; et al. Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals. Mar. Drugs 2021, 19, 614. [Google Scholar] [CrossRef] [PubMed]
  14. Umayaparvathi, S.; Meenakshi, S.; Vimalraj, V.; Arumugam, M.; Sivagami, G.; Balasubramanian, T. Antioxidant activity and anticancer effect of bioactive peptide from enzymatic hydrolysate of oyster (Saccostrea cucullata). Biomed. Prev. Nutr. 2014, 4, 343–353. [Google Scholar] [CrossRef]
  15. Zhang, C.; Li, X.; Jing, X.; Zhang, B.; Zhang, Q.; Niu, Q.; Wang, J.; Tian, Z. Protective effects of oyster extract against hepatic tissue injury in alcoholic liver diseases. J. Ocean Univ. China 2014, 13, 262–270. [Google Scholar] [CrossRef]
  16. Li, H.; Xia, X.; Zang, J.; Tan, X.; Wang, Z.; Xu, X.; Du, M. Oyster (Crassostrea gigas) ferritin can efficiently reduce the damage of Pb2+ in vivo by electrostatic attraction. Int. J. Biol. Macromol. 2022, 210, 365–376. [Google Scholar] [CrossRef]
  17. Harnedy, P.A.; FitzGerald, R.J. Bioactive peptides from marine processing waste and shellfish: A review. J. Funct. Foods 2012, 4, 6–24. [Google Scholar] [CrossRef]
  18. Rakesh, K.P.; Suhas, R.; Gowda, D.C. Anti-inflammatory and Antioxidant Peptide-Conjugates: Modulation of Activity by Charged and Hydrophobic Residues. In. J. Pept. Res. Ther. 2019, 25, 227–234. [Google Scholar] [CrossRef]
  19. Mahmood, S.; Wahid, A.; Azeem, M.; Zafar, S.; Bashir, R.; Sharif, O.; Ali, S. Tyrosine or lysine priming modulated phenolic metabolism and improved cadmium stress tolerance in mung bean (Vigna radiata L.). S. Afr. J. Bot. 2022, 149, 397–406. [Google Scholar] [CrossRef]
  20. Zemanová, V.; Pavlík, M.; Pavlíková, D.; Tlustoš, P. The significance of methionine, histidine and tryptophan in plant responses and adaptation to cadmium stress. Plant Soil Environ. 2014, 60, 426–432. [Google Scholar] [CrossRef] [Green Version]
  21. Domínguez-Solís, J.R.; López-Martín, M.C.; Ager, F.J.; Ynsa, M.D.; Romero, L.C.; Gotor, C. Increased cysteine availability is essential for cadmium tolerance and accumulation in Arabidopsis thaliana. Plant Biotechnol. J. 2004, 2, 469–476. [Google Scholar] [CrossRef] [PubMed]
  22. Islam, M.M.; Hoque, M.A.; Okuma, E.; Banu, M.N.A.; Shimoishi, Y.; Nakamura, Y.; Murata, Y. Exogenous proline and glycinebetaine increase antioxidant enzyme activities and confer tolerance to cadmium stress in cultured tobacco cells. J. Plant Physiol. 2009, 166, 1587–1597. [Google Scholar] [CrossRef] [PubMed]
  23. Born, T.; Kontoghiorghe, C.N.; Spyrou, A.; Kolnagou, A.; Kontoghiorghes, G.J. EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: Review of preliminary findings and risk/benefit assessment. Toxicol. Mech. Methods 2013, 23, 11–17. [Google Scholar] [CrossRef] [PubMed]
  24. Michael, B.; Yano, B.; Sellers, R.S.; Perry, R.; Morton, D.; Roome, N.; Johnson, J.K.; Schafer, K. Evaluation of Organ Weights for Rodent and Non-Rodent Toxicity Studies: A Review of Regulatory Guidelines and a Survey of Current Practices. Toxicol. Pathol. 2007, 35, 742–750. [Google Scholar] [CrossRef]
  25. Arranz, J.; Soriano, A.; Garcia, I.; García, I.; Concepción, M.T.; Navarro, J.; Arteaga, A.; Filella, X.; Bravo, P.; Barrera, M.; et al. Effect of proinflammatory cytokines (IL-6, TNF-α, IL-1β) on hemodynamic performance during orthotopic liver transplantation. Transpl. P. 2003, 35, 1884–1887. [Google Scholar] [CrossRef]
  26. Arras, D.S.; John, S.R. IL-6 pathway in the liver: From physiopathology to therapy. J. Hepatol. 2016, 64, 1403–1415. [Google Scholar] [CrossRef] [Green Version]
  27. Schwabe, R.F.; Brenner, D.A. Mechanisms of Liver Injury. I. TNF-α-induced liver injury: Role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastr. L. 2006, 290, G583–G589. [Google Scholar] [CrossRef]
  28. Yu, J.; Ip, E.; dela Peña, A.; Hou, J.Y.; Sesha, J.; Pera, N.; Hall, P.; Kirsch, R.; Leclercq, I.; Farrell, G.C. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology 2006, 43, 826–836. [Google Scholar] [CrossRef]
  29. Zhao, Y.; Huang, S.; Liu, J.; Wu, X.; Zhou, S.; Dai, K.; Kou, Y. Mitophagy Contributes to the Pathogenesis of Inflammatory Diseases. Inflammation 2018, 41, 1590–1600. [Google Scholar] [CrossRef]
  30. Huang, Y.-Y.; Xia, M.-Z.; Wang, H.; Liu, X.-J.; Hu, Y.-F.; Chen, Y.-H.; Zhang, C.; Xu, D.-X. Cadmium Selectively Induces MIP-2 and COX-2 Through PTEN-Mediated Akt Activation in RAW264.7 Cells. Toxicol. Sci. 2014, 138, 310–321. [Google Scholar] [CrossRef] [Green Version]
  31. Zhang, Y.; Li, Y.; Zhang, J.; Qi, X.; Cui, Y.; Yin, K.; Lin, H. Cadmium induced inflammation and apoptosis of porcine epididymis via activating RAF1/MEK/ERK and NF-κB pathways. Toxicol. Appl. Pharmacol. 2021, 415, 115449. [Google Scholar] [CrossRef] [PubMed]
  32. Habeebu, S.S.M.; Liu, J.; Klaassen, C.D. Cadmium-Induced Apoptosis in Mouse Liver. Toxicol. Appl. Pharm. 1998, 149, 203–209. [Google Scholar] [CrossRef] [PubMed]
  33. Thomadaki, H.; Scorilas, A. BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer. Crit. Rev. Clin. Lab. Sci. 2006, 43, 1–67. [Google Scholar] [CrossRef] [PubMed]
  34. Yiming, L.; Yanfei, H.; Hang, Y.; Yimei, C.; Guangliang, S.; Shu, L. Cadmium induces apoptosis of pig lymph nodes by regulating the PI3K/AKT/HIF-1α pathway. Toxicology 2021, 451, 152694. [Google Scholar] [CrossRef] [PubMed]
  35. Cui, W.; Zhou, S.; Wang, Y.; Shi, X.; Liu, H. Cadmium exposure activates the PI3K/AKT signaling pathway through miRNA-21, induces an increase in M1 polarization of macrophages, and leads to fibrosis of pig liver tissue. Ecotoxicol. Environ. Saf. 2021, 228, 113015. [Google Scholar] [CrossRef] [PubMed]
  36. Rodríguez Barbero, A.; Dorado, F.; Velasco, S.; Pandiella, A.; Banas, B.; López Novoa, J.M. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int. 2006, 70, 901–909. [Google Scholar] [CrossRef]
  37. Matović, V.; Buha, A.; Ðukić-Ćosić, D.; Bulat, Z. Insight into the oxidative stress induced by lead and/or cadmium in blood, liver and kidneys. Food Chem. Toxicol. 2015, 78, 130–140. [Google Scholar] [CrossRef]
  38. Wu, H.-C.; Chen, H.-M.; Shiau, C.-Y. Free amino acids and peptides as related to antioxidant properties in protein hydrolysates of mackerel (Scomber austriasicus). Food Res. Int. 2003, 36, 949–957. [Google Scholar] [CrossRef]
  39. Nasri, M. Chapter Four—Protein Hydrolysates and Biopeptides: Production, Biological Activities, and Applications in Foods and Health Benefits. A Review. In Advances in Food and Nutrition Research; Toldrá, F., Ed.; Academic Press: Cambridge, MA, USA, 2017; pp. 109–159. [Google Scholar]
  40. Ghaly, A.E.; Vv, R.; Brooks, M.S.-L.; Budge, S.M.; Dave, D. Fish Processing Wastes as a Potential Source of Proteins, Amino Acidsand Oils: A Critical Review. J. Microb. Biochem. Technol. 2013, 2, 107–129. [Google Scholar]
  41. Yang, B.; Yang, H.; Li, J.; Li, Z.; Jiang, Y. Amino acid composition, molecular weight distribution and antioxidant activity of protein hydrolysates of soy sauce lees. Food Chem. 2011, 124, 551–555. [Google Scholar] [CrossRef]
  42. Rania, J.H.; Hassan, H.M.M.; Afify, A.S. Evaluation of Antioxidant and Metal Chelating Activities of Protein Hydrolysates Produced from Leather Waste by Alkaline and Enzymatic Hydrolysis. Res. J. Pharm. Biol. Chem. Sci. 2016, 7, 910–919. [Google Scholar]
  43. Gu, H.; Song, I.-B.; Han, H.-J.; Lee, N.-Y.; Cha, J.-Y.; Son, Y.-K.; Kwon, J. Antioxidant Activity of Royal Jelly Hydrolysates Obtained by Enzymatic Treatment. Korean J. Food Sci. Anim. Resour. 2018, 38, 135–142. [Google Scholar] [PubMed]
  44. Ovissipour, M.; Rasco, B.; Shiroodi, S.G.; Modanlow, M.; Gholami, S.; Nemati, M. Antioxidant activity of protein hydrolysates from whole anchovy sprat (Clupeonella engrauliformis) prepared using endogenous enzymes and commercial proteases. J. Sci. Food Agric. 2013, 93, 1718–1726. [Google Scholar] [CrossRef] [PubMed]
  45. DeRosa, G.; Swick, R.W. Metabolic implications of the distribution of the alanine aminotransferase isoenzymes. J. Biol. Chem. 1975, 250, 7961–7967. [Google Scholar] [CrossRef]
  46. Fernando, S.; Wijewickrama, A.; Gomes, L.; Punchihewa, C.T.; Madusanka, S.D.; Dissanayake, H.; Jeewandara, C.; Peiris, H.; Ogg, G.S.; Malavige, G.N. Patterns and causes of liver involvement in acute dengue infection. BMC Infect. Dis. 2016, 16, 319. [Google Scholar] [CrossRef] [Green Version]
  47. Noor, K.K.; Ijaz, M.U.; Ehsan, N.; Tahir, A.; Yeni, D.K.; Neamul Kabir Zihad, S.M.; Uddin, S.J.; Ashraf, A.; Simal-Gandara, J. Hepatoprotective role of vitexin against cadmium-induced liver damage in male rats: A biochemical, inflammatory, apoptotic and histopathological investigation. Biomed. Pharmacother. 2022, 150, 112934. [Google Scholar] [CrossRef]
  48. Wang, K.; Shi, J.; Gao, S.; Hong, H.; Tan, Y.; Luo, Y. Oyster protein hydrolysates alleviated chronic alcohol-induced liver injury in mice by regulating hepatic lipid metabolism and inflammation response. Food Res. Int. 2022, 160, 111647. [Google Scholar] [CrossRef]
  49. Shi, Y.; Sun, J.; He, H.; Guo, H.; Zhang, S. Hepatoprotective effects of Ganoderma lucidum peptides against d-galactosamine-induced liver injury in mice. J. Ethnopharmacol. 2008, 117, 415–419. [Google Scholar] [CrossRef]
  50. Mumtaz, S.; Ali, S.; Khan, R.; Andleeb, S.; Ulhaq, M.; Khan, M.A.; Shakir, H.A. The protective role of ascorbic acid in the hepatotoxicity of cadmium and mercury in rabbits. Environ. Sci. Pollut. R. 2019, 26, 14087–14096. [Google Scholar] [CrossRef]
  51. Holeček, M.; Mráz, J.; Tilšer, I. Plasma amino acids in four models of experimental liver injury in rats. Amino Acids 1996, 10, 229–241. [Google Scholar] [CrossRef]
  52. Ryu, B.; Shin, K.-H.; Kim, S.-K. Muscle Protein Hydrolysates and Amino Acid Composition in Fish. Mar. Drugs 2021, 19, 377. [Google Scholar] [CrossRef] [PubMed]
  53. Hayat, S.; Hayat, Q.; Alyemeni, M.N.; Wani, A.S.; Pichtel, J.; Ahmad, A. Role of proline under changing environments. Plant Signal. Behav. 2012, 7, 1456–1466. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Obayashi, Y.; Arisaka, H.; Yoshida, S.; Mori, M.; Takahashi, M. Proline protects liver from d-galactosamine hepatitis by activating the IL-6/STAT3 survival signaling pathway. Amino Acids 2012, 43, 2371–2380. [Google Scholar] [CrossRef] [PubMed]
  55. Xie, S.-W.; Tian, L.-X.; Li, Y.-M.; Zhou, W.; Zeng, S.-L.; Yang, H.-J.; Liu, Y.-J. Effect of proline supplementation on anti-oxidative capacity, immune response and stress tolerance of juvenile Pacific white shrimp, Litopenaeus vannamei. Aquaculture 2015, 448, 105–111. [Google Scholar] [CrossRef]
  56. Zhang, L.; Xu, L.; Chen, Y.; Ni, Q.I.; Zhou, M.; Qu, C.; Zhang, Y. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats. World J. Gastroenterol. 2012, 18, 5283–5288. [Google Scholar]
  57. Gujjar, R.; Pathak, A.D.; Karkute, S.; Supaibulwattana, K. Multifunctional proline rich proteins and their role in regulating cellular proline content in plants under stress. Biol. Plant. 2019, 63, 448–454. [Google Scholar] [CrossRef]
  58. Yao Chai, T.; Didierjean, L.; Burkard, G.; Genot, G. Expression of a green tissue-specific 11 kDa proline-rich protein gene in bean in response to heavy metals. Plant Sci. 1998, 133, 47–56. [Google Scholar] [CrossRef]
  59. Kavi Kishor, P.B.; Sreenivasulu, N. Is proline accumulation per se correlated with stress tolerance or is proline homeostasis a more critical issue? Plant Cell Environ. 2014, 37, 300–311. [Google Scholar] [CrossRef]
  60. Komatsu, T.; Kobayashi, K.; Morimoto, Y.; Helmerhorst, E.; Oppenheim, F.; Chang-Il Lee, M. Direct evaluation of the antioxidant properties of salivary proline-rich proteins. J. Clin. Biochem. Nutr. 2020, 67, 131–136. [Google Scholar] [CrossRef]
  61. Galoyan, A.A.; Shakhlamov, V.A.; Aghajanov, M.I.; Vahradyan, H.G. Hypothalamic Proline-Rich Polypeptide Protects Brain Neurons in Aluminum Neurotoxicosis. Neurochem. Res. 2004, 29, 1349–1357. [Google Scholar] [CrossRef]
  62. Das, S.C.; Al-Naemi, H.A. Cadmium Toxicity: Oxidative Stress, Inflammation and Tissue Injury. Occup. Dis. Environ. Med. 2019, 7, 144–163. [Google Scholar] [CrossRef] [Green Version]
  63. Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160, 1–40. [Google Scholar] [CrossRef] [PubMed]
  64. Poli, G.; Albano, E.; Dianzani, M.U. The role of lipid peroxidation in liver damage. Chem. Phys. Lipids 1987, 45, 117–142. [Google Scholar] [CrossRef] [PubMed]
  65. Wang, J.; Zhang, Y.; Fang, Z.; Sun, L.; Wang, Y.; Liu, Y.; Xu, D.; Nie, F.; Gooneratne, R. Oleic Acid Alleviates Cadmium-Induced Oxidative Damage in Rat by Its Radicals Scavenging Activity. Biol. Trace Elem. Res. 2019, 190, 95–100. [Google Scholar] [CrossRef] [PubMed]
  66. Elsayed, A.; Elkomy, A.; Elkammar, R.; Youssef, G.; Abdelhiee, E.Y.; Abdo, W.; Fadl, S.E.; Soliman, A.; Aboubakr, M. Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats. Sci. Rep. 2021, 11, 13979. [Google Scholar] [CrossRef] [PubMed]
  67. Elsayed, A.; Elkomy, A.; Alkafafy, M.; Elkammar, R.; Fadl, S.E.; Abdelhiee, E.Y.; Abdeen, A.; Youssef, G.; Shaheen, H.; Soliman, A.; et al. Ameliorating Effect of Lycopene and N-Acetylcysteine against Cisplatin-Induced Cardiac Injury in Rats. Pak. Vet. J. 2022, 42, 107–111. [Google Scholar]
  68. Elsayed, A.; Elkomy, A.; Alkafafy, M.; Elkammar, R.; El-Shafey, A.; Soliman, A.; Aboubakr, M. Testicular toxicity of cisplatin in rats: Ameliorative effect of lycopene and N-acetylcysteine. Environ. Sci. Pollut. R. 2022, 29, 24077–24084. [Google Scholar] [CrossRef]
  69. Fan, R.; Hu, P.-C.; Wang, Y.; Lin, H.-Y.; Su, K.; Feng, X.-S.; Wei, L.; Yang, F. Betulinic acid protects mice from cadmium chloride-induced toxicity by inhibiting cadmium-induced apoptosis in kidney and liver. Toxicol. Lett. 2018, 299, 56–66. [Google Scholar] [CrossRef]
  70. Shaikh, Z.A.; Vu, T.T.; Zaman, K. Oxidative Stress as a Mechanism of Chronic Cadmium-Induced Hepatotoxicity and Renal Toxicity and Protection by Antioxidants. Toxicol. Appl. Pharmacol. 1999, 154, 256–263. [Google Scholar] [CrossRef]
  71. Jemai, H.; Messaoudi, I.; Chaouch, A.; Kerkeni, A. Protective effect of zinc supplementation on blood antioxidant defense system in rats exposed to cadmium. J. Trace Elem. Med. Biol. 2007, 21, 269–273. [Google Scholar] [CrossRef]
  72. Jemai, H.; Mahmoudi, A.; Feryeni, A.; Fki, I.; Bouallagui, Z.; Choura, S.; Chamkha, M.; Sayadi, S. Hepatoprotective Effect of Oleuropein-Rich Extract from Olive Leaves against Cadmium-Induced Toxicity in Mice. Biomed. Res. Int. 2020, 2020, 4398924. [Google Scholar] [CrossRef] [Green Version]
  73. Li, Y.; Yu, J. Research Progress in Structure-Activity Relationship of Bioactive Peptides. J. Med. Food 2014, 18, 147–156. [Google Scholar] [CrossRef] [PubMed]
  74. Zhu, L.; Chen, J.; Tang, X.; Xiong, Y.L. Reducing, Radical Scavenging, and Chelation Properties of in Vitro Digests of Alcalase-Treated Zein Hydrolysate. J. Agric. Food Chem. 2008, 56, 2714–2721. [Google Scholar] [CrossRef] [PubMed]
  75. Zou, T.-B.; He, T.-P.; Li, H.-B.; Tang, H.-W.; Xia, E.-Q. The Structure-Activity Relationship of the Antioxidant Peptides from Natural Proteins. Molecules 2016, 21, 72. [Google Scholar] [CrossRef]
  76. Wree, A.; Holtmann, T.M.; Inzaugarat, M.E.; Feldstein, A.E. Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis. Semin. Liver Dis. 2019, 39, 275–282. [Google Scholar] [CrossRef] [PubMed]
  77. Diao, L.; Li, N.; Brayman, T.G.; Hotz, K.J.; Lai, Y. Regulation of MRP2/ABCC2 and BSEP/ABCB11 Expression in Sandwich Cultured Human and Rat Hepatocytes Exposed to Inflammatory Cytokines TNF-α, IL-6, and IL-1β. J. Biol. Chem. 2010, 285, 31185–31192. [Google Scholar] [CrossRef] [Green Version]
  78. Zhao, Z.; Hyun, J.S.; Satsu, H.; Kakuta, S.; Shimizu, M. Oral exposure to cadmium chloride triggers an acute inflammatory response in the intestines of mice, initiated by the over-expression of tissue macrophage inflammatory protein-2 mRNA. Toxicol. Lett. 2006, 164, 144–154. [Google Scholar] [CrossRef]
  79. Qian, B.; Zhao, X.; Yang, Y.; Tian, C. Antioxidant and anti-inflammatory peptide fraction from oyster soft tissue by enzymatic hydrolysis. Food Sci. Nutr. 2020, 8, 3947–3956. [Google Scholar] [CrossRef]
  80. Li, S.; Sun, W.; Zhang, K.; Zhu, J.; Jia, X.; Guo, X.; Zhao, Q.; Tang, C.; Yin, J.; Zhang, J. Selenium deficiency induces spleen pathological changes in pigs by decreasing selenoprotein expression, evoking oxidative stress, and activating inflammation and apoptosis. J. Anim. Sci. Biotechno. 2021, 12, 65. [Google Scholar] [CrossRef]
  81. Peng, Z.; Chen, B.; Zheng, Q.; Zhu, G.; Cao, W.; Qin, X.; Zhang, C. Ameliorative Effects of Peptides from the Oyster (Crassostrea hongkongensis) Protein Hydrolysates against UVB-Induced Skin Photodamage in Mice. Mar. Drugs 2020, 18, 288. [Google Scholar] [CrossRef]
  82. Qian, Z.-J.; Chen, M.-F.; Chen, J.; Zhang, Y.; Zhou, C.; Hong, P.; Yang, P. Intracellular ethanol-mediated oxidation and apoptosis in HepG2/CYP2E1 cells impaired by two active peptides from seahorse (Hippocampus kuda bleeler) protein hydrolysates via the Nrf2/HO-1 and akt pathways. Food Sci. Nutr. 2021, 9, 1584–1602. [Google Scholar] [CrossRef] [PubMed]
  83. Li, Y.; Lu, L.; Luo, N.; Wang, Y.Q.; Gao, H.M. Inhibition of PI3K/AKt/mTOR signaling pathway protects against d-galactosamine/lipopolysaccharide-induced acute liver failure by chaperone-mediated autophagy in rats. Biomed Pharm. 2017, 92, 544–553. [Google Scholar] [CrossRef] [PubMed]
  84. Zhong, W.; Qian, K.; Xiong, J.; Ma, K.; Wang, A.; Zou, Y. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-kappaB related signaling. Biomed. Pharm. 2016, 83, 302–313. [Google Scholar] [CrossRef] [PubMed]
  85. Wang, Y.; Gu, J.; Hu, L.; Kong, L.; Wang, T.; Di, M.; Li, C.; Gui, S. miR-130a alleviates neuronal apoptosis and changes in expression of Bcl-2/Bax and caspase-3 in cerebral infarction rats through PTEN/PI3K/Akt signaling pathway. Exp. Med. 2020, 19, 2119–2126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Xiong, X.; Zhang, Y.; Xing, H.; Xu, S. Ameliorative Effect of Selenomethionine on Cadmium-Induced Hepatocyte Apoptosis via Regulating PI3K/AKT Pathway in Chickens. Biol. Trace Elem. Res. 2020, 195, 559–568. [Google Scholar] [CrossRef] [PubMed]
  87. Augustine, N.; Ani, C.; Eze, W.; Ugwudike, P.; Anyaeji, P.; Ude, V.C.; Agu, F.U.; Nworgu, C.; Ikwuka, D.; Ugwuishi, E.; et al. The effect of aqueous extract of zest of citrus sinensis (AEZCs) on cadmium chloride induced liver toxicity in wistar rats. Afr. J. Biochem. R. 2020, 14, 5–17. [Google Scholar] [CrossRef] [Green Version]
  88. Najeeb, U.; Jilani, G.; Ali, S.; Sarwar, M.; Xu, L.; Zhou, W. Insights into cadmium induced physiological and ultra-structural disorders in Juncus effusus L. and its remediation through exogenous citric acid. J. Hazard. Mater. 2011, 186, 565–574. [Google Scholar] [CrossRef]
  89. El-Naggar, S.A.; El-Said, K.S.; Elwan, M.; Mobasher, M.; Mansour, F.; Elbakry, M.; Kabil, D.I. Toxicity of bean cooking media containing EDTA in mice. Toxicol. Ind. Health 2020, 36, 436–445. [Google Scholar] [CrossRef]
  90. Zhang, X.; Peng, Z.; Zheng, H.; Zhang, C.; Lin, H.; Qin, X. The Potential Protective Effect and Possible Mechanism of Peptides from Oyster (Crassostrea hongkongensis) Hydrolysate on Triptolide-Induced Testis Injury in Male Mice. Mar. Drugs 2021, 19, 566. [Google Scholar] [CrossRef]
  91. Jansen, R.; Lachatre, G.; Marquet, P. LC-MS/MS systematic toxicological analysis: Comparison of MS/MS spectra obtained with different instruments and settings. Clin. Biochem. 2005, 38, 362–372. [Google Scholar] [CrossRef]
  92. Łozowicka, B.; Kaczyński, P.; Iwaniuk, P. Analysis of 22 free amino acids in honey from Eastern Europe and Central Asia using LC-MS/MS technique without derivatization step. J. Food Compos. Anal. 2021, 98, 103837. [Google Scholar] [CrossRef]
  93. He, S.; Zhuo, L.; Cao, Y.; Liu, G.; Zhao, H.; Song, R.; Liu, Z. Effect of cadmium on osteoclast differentiation during bone injury in female mice. Environ. Toxicol. 2020, 35, 487–494. [Google Scholar] [CrossRef] [PubMed]
  94. Zhu, Y.; Chen, X.; Rao, X.; Zheng, C.; Peng, X. Saikosaponin a ameliorates lipopolysaccharide and d-galactosamine-induced liver injury via activating LXRα. Int. Immunopharmacol. 2019, 72, 131–137. [Google Scholar] [CrossRef]
  95. Yang, P.; Xu, F.; Li, H.-F.; Wang, Y.; Li, F.-C.; Shang, M.-Y.; Liu, G.-X.; Wang, X.; Cai, S.-Q. Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MSn. Molecules 2016, 21, 1209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Fornetti, J.; Jindal, S.; Middleton, K.; Borges, V.; Schedin, P. Physiological COX-2 Expression in Breast Epithelium Associates with COX-2 Levels in Ductal Carcinoma in Situ and Invasive Breast Cancer in Young Women. Am. J. Pathol. 2014, 184, 1220–1229. [Google Scholar] [CrossRef]
  97. He, Q.; Luo, Y.; Xie, Z. Sulforaphane ameliorates cadmium induced hepatotoxicity through the up-regulation of /Nrf2/ARE pathway and the inactivation of NF-κB. J. Funct. Foods 2021, 77, 104297. [Google Scholar] [CrossRef]
Marinedrugs 20 00758 g001 550
Figure 1. Total ion chromatogram of peptides from oyster enzymatic hydrolysates (OPs).
Figure 1. Total ion chromatogram of peptides from oyster enzymatic hydrolysates (OPs).
Marinedrugs 20 00758 g001
Marinedrugs 20 00758 g002 550
Figure 2. Effect of OPs on the liver function profiles in mice (A) ALT: Alanine aminotransferase; (B) AST: Aspartate aminotransferase; (C) ALP: Alkaline phosphatase; (D) LDH: Lactate dehydrogenase; Control: Intraperitoneal injection of 0.9% NaCl (saline) once daily; Cd: Mice were injected intraperitoneally with CdCl2 5 mg/kg daily; EDTA: Mice were injected with CdCl2 (5 mg/kg) intraperitoneally after 1 h of oral administration with EDTA (100 mg/kg) daily; Cd+L-OPs: Mice were injected with CdCl2 (5 mg/kg) intra-peritoneally after 1 h of oral administration with a low dose of OPs (100 mg/kg) daily. Mice were injected with CdCl2 (5 mg/kg) intra-peritoneally after 1 h of oral administration with a high dose of OPs (300 mg/kg) daily. The data were expressed as mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, ## p < 0.01.
Figure 2. Effect of OPs on the liver function profiles in mice (A) ALT: Alanine aminotransferase; (B) AST: Aspartate aminotransferase; (C) ALP: Alkaline phosphatase; (D) LDH: Lactate dehydrogenase; Control: Intraperitoneal injection of 0.9% NaCl (saline) once daily; Cd: Mice were injected intraperitoneally with CdCl2 5 mg/kg daily; EDTA: Mice were injected with CdCl2 (5 mg/kg) intraperitoneally after 1 h of oral administration with EDTA (100 mg/kg) daily; Cd+L-OPs: Mice were injected with CdCl2 (5 mg/kg) intra-peritoneally after 1 h of oral administration with a low dose of OPs (100 mg/kg) daily. Mice were injected with CdCl2 (5 mg/kg) intra-peritoneally after 1 h of oral administration with a high dose of OPs (300 mg/kg) daily. The data were expressed as mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, ## p < 0.01.
Marinedrugs 20 00758 g002
Marinedrugs 20 00758 g003 550
Figure 3. Effects of OPs on liver coefficient and hepatic injury in Cd-exposed mice. (A) Liver coefficient = liver weight(g)/mouse weight(g); (B) Histopathology with H&E staining (200×) of the liver in mice after treatment for 7 days; CV: Central veins; Arrow: lymphocyte accumulation in the parenchyma; asterisk (*): hemorrhage. Bar = 100 μm. The data were expressed as mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, ## p < 0.01.
Figure 3. Effects of OPs on liver coefficient and hepatic injury in Cd-exposed mice. (A) Liver coefficient = liver weight(g)/mouse weight(g); (B) Histopathology with H&E staining (200×) of the liver in mice after treatment for 7 days; CV: Central veins; Arrow: lymphocyte accumulation in the parenchyma; asterisk (*): hemorrhage. Bar = 100 μm. The data were expressed as mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, ## p < 0.01.
Marinedrugs 20 00758 g003
Marinedrugs 20 00758 g004 550
Figure 4. Effects of OPs on MDA level, SOD, CAT, and GSH-Px activities in Cd-induced mice. (A) Malondialdehyde (MDA); (B) Superoxide dismutase (SOD); (C) Catalase (CAT); (D) Glutathione peroxidase (GSH-Px). The data were expressed as mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, # p < 0.05, ## p < 0.01.
Figure 4. Effects of OPs on MDA level, SOD, CAT, and GSH-Px activities in Cd-induced mice. (A) Malondialdehyde (MDA); (B) Superoxide dismutase (SOD); (C) Catalase (CAT); (D) Glutathione peroxidase (GSH-Px). The data were expressed as mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, # p < 0.05, ## p < 0.01.
Marinedrugs 20 00758 g004
Marinedrugs 20 00758 g005 550
Figure 5. Effect of OPs on inflammatory factor levels and mRNA expression on hepatic in Cd-exposed mice. (A) IL-1β level; (B) IL-6 level; (C) TNF-α level; (D–F) Hepatic mRNA expression levels of IL-1β, IL-6, and TNF-α in different groups. These data are expressed as the mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, # p < 0.05, ## p < 0.01.
Figure 5. Effect of OPs on inflammatory factor levels and mRNA expression on hepatic in Cd-exposed mice. (A) IL-1β level; (B) IL-6 level; (C) TNF-α level; (D–F) Hepatic mRNA expression levels of IL-1β, IL-6, and TNF-α in different groups. These data are expressed as the mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, # p < 0.05, ## p < 0.01.
Marinedrugs 20 00758 g005
Marinedrugs 20 00758 g006 550
Figure 6. Effect of OPs on the expression of COX-2, MIP-2, NF-κB, and p-ERK in the liver. (A) The expression of COX-2 and MIP-2 in the liver by Immunohistochemical (IHC) Staining; (B) Western blot analysis of NF-κB and p-ERK proteins, Cd was sampled in 10 µL and 20 µL volumes, respectively; (C) Quantitative densitometric analysis of NF-κB and p-ERK proteins. These Data are expressed as the mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, ## p < 0.01.
Figure 6. Effect of OPs on the expression of COX-2, MIP-2, NF-κB, and p-ERK in the liver. (A) The expression of COX-2 and MIP-2 in the liver by Immunohistochemical (IHC) Staining; (B) Western blot analysis of NF-κB and p-ERK proteins, Cd was sampled in 10 µL and 20 µL volumes, respectively; (C) Quantitative densitometric analysis of NF-κB and p-ERK proteins. These Data are expressed as the mean ± SEM, n = 6 in each group. Compared with the control group, ** p < 0.01; compared with the Cd group, ## p < 0.01.
Marinedrugs 20 00758 g006
Marinedrugs 20 00758 g007 550
Figure 7. Effect of OPs on apoptotic marker levels and mRNA expression of Cd-induced mice in the liver. (A) Bax concentration; (B) Caspase-3 activity; (C) Bcl-2 concentration; (D) Relative mRNA expression levels of Bax, caspase-3 and Bcl-2; (E) Western blot analysis of PI3k, p-AKT, Bax, caspase-3 and Bcl-2 protein expression, Cd was sampled in 10 µL and 20 µL volumes, respectively; (F) The quantitative densitometric analysis of PI3k, p-AKT, Bax, caspase-3 and Bcl-2. These Data are expressed as the mean ± SEM, n = 6 in each group. Compared with the control group, * p < 0.05, ** p < 0.01; compared with the Cd group, # p < 0.05, ## p < 0.01.
Figure 7. Effect of OPs on apoptotic marker levels and mRNA expression of Cd-induced mice in the liver. (A) Bax concentration; (B) Caspase-3 activity; (C) Bcl-2 concentration; (D) Relative mRNA expression levels of Bax, caspase-3 and Bcl-2; (E) Western blot analysis of PI3k, p-AKT, Bax, caspase-3 and Bcl-2 protein expression, Cd was sampled in 10 µL and 20 µL volumes, respectively; (F) The quantitative densitometric analysis of PI3k, p-AKT, Bax, caspase-3 and Bcl-2. These Data are expressed as the mean ± SEM, n = 6 in each group. Compared with the control group, * p < 0.05, ** p < 0.01; compared with the Cd group, # p < 0.05, ## p < 0.01.
Marinedrugs 20 00758 g007
Marinedrugs 20 00758 g008 550
Figure 8. Schematic representation of OPs improved mechanisms of cadmium-induced oxidative stress, inflammation, and apoptosis in mice.
Figure 8. Schematic representation of OPs improved mechanisms of cadmium-induced oxidative stress, inflammation, and apoptosis in mice.
Marinedrugs 20 00758 g008
Table
Table 1. Main peptide sequences of OPs.
Table 1. Main peptide sequences of OPs.
RankPeptide SequenceLengthMolecular Mass (Da)Observed Mass (m/z)Peak AreaRelative
Peak Area (%)		Scores
1GEPGPEGPAGPIGPR151387.697694.35018,567,0000.15614.6
2YEETRGVLK91094.584547.7959,895,9000.08494.2
3GPTGPVGPL9794.441794.4373,857,4000.03477.2
4GPSGEPGPE9826.358826.35412,054,0000.10468.7
5DIERPTYT8994.484497.74518,359,0000.15461.4
6ENPVPVPS8838.431838.4276,999,2000.06453.3
7TEAPLNPK8869.473869.4719,380,4000.08451.1
8TPEEFIPR8988.510494.75812,323,0000.10437.8
9AGFAGDDAPR10976.448488.727171,200,0001.39430.9
10TPTYGDL7766.362766.35946,716,0000.38428.1
11PDVPAGDVDKGK121197.611399.87414,901,0000.12425.1
12GPIGGPL7610.356610.3545,358,1000.04423.7
13SPVGVGA7586.320586.31813,332,0000.11411.4
14YTPVAYPV8586.320586.3184,007,5000.03388.5
15LTPSGLPY8647.342647.34214,591,0000.12386.7
16STPFEGF7571.308571.30813,332,0000.11384.4
17VSDTVVEPYN10550.250550.25027,505,0000.22383.3
18DIERPTYTN9909.420909.4208,461,1000.07383.2
19QGETGDRGPFG11879.456440.23134,716,0000.28383.0
20PRPPTQVGGS10995.525498.26638,429,0000.31382.8
Table
Table 2. Composition and content of amino acids in OPs.
Table 2. Composition and content of amino acids in OPs.
Amino AcidsContents (g/100 g)Amino AcidsContents (g/100 g)
Alanine (Ala) #2.63Leucine (Leu) *#2.02
Cystine (Cys)0.40Methionine (Met) *#0.65
Aspartic acid (Asp)3.36Proline (Pro) #2.61
Glutamic acid (Glu)4.33Arginine (Arg)1.71
Phenylalanine (Phe) *#0.72Serine (Ser)1.83
Glycine (Gly)2.92Threonine (Thr) *1.69
Histidine (His)0.50Valine (Val) *#1.81
Isoleucine (Ile) *#1.40Tyrosine (Tyr) 1.62
Lysine (Lys) *2.61Tryptophan (Trp) *#0.92
Total amino acids33.73
Essential amino acid11.82
Hydrophobic amino acids12.76
Note: * Essential amino acids. # Hydrophobic amino acids.
Table
Table 3. Contents of free amino acids in OPs.
Table 3. Contents of free amino acids in OPs.
Free Amino AcidsContents (g/100 g)Free Amino AcidsContents (g/100 g)
Ala #0.59 Met *#0.36
CysNDAsn0.26
Asp0.37 Pro #2.49
Glu2.12Gln0.85
Phe *#0.18Arg0.53
Gly1.38Ser0.29
His0.08Thr *0.84
Ile *#0.59 Val *#0.91
Lys *1.43 Trp *#0.52
Leu *#0.50 Tyr1.51
Total free amino acids15.80
Essential free amino acid5.33
Hydrophobic free amino acids6.14
Note: * Essential free amino acids. # Hydrophobic free amino acids; ND: not detected.
Table
Table 4. Primer sequences for qRT-PCR analyses.
Table 4. Primer sequences for qRT-PCR analyses.
Gene NameForward Primer (5′–3′)Reverse Primer (5′–3′)
IL-1βGACTTCACCATGGAACCCGTGGAGACTGCCCATTCTCGAC
IL-6GGCCCTTGCTTTCTCTTCGATAATAAAGTTTTGATTATGT
TNF-αAGCCCTGGTATGAGCCCATGTACCGGACTCCGTGATGTCTAAGT
BaxCTGAGCTGACCTTGGAGCGACTCCAGCCACAAGAGATG
Caspase-3GAGCTTGGAACGGTACGCTACCGTACCAGAGCGAGATGAC
Bcl-2GACAGAAGATCATGCCGTCCGGTACCAATGGCACTTCAAG
GAPDHTCACCACCATGGAGAAGGCGCTAAGCAGTTGGTGGTGCA
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, J.; Fang, Z.; Li, Y.; Sun, L.; Liu, Y.; Deng, Q.; Zhong, S. Ameliorative Effects of Oyster Protein Hydrolysates on Cadmium-Induced Hepatic Injury in Mice. Mar. Drugs 2022, 20, 758. https://doi.org/10.3390/md20120758

AMA Style

Wang J, Fang Z, Li Y, Sun L, Liu Y, Deng Q, Zhong S. Ameliorative Effects of Oyster Protein Hydrolysates on Cadmium-Induced Hepatic Injury in Mice. Marine Drugs. 2022; 20(12):758. https://doi.org/10.3390/md20120758

Chicago/Turabian Style

Wang, Jingwen, Zhijia Fang, Yongbin Li, Lijun Sun, Ying Liu, Qi Deng, and Saiyi Zhong. 2022. "Ameliorative Effects of Oyster Protein Hydrolysates on Cadmium-Induced Hepatic Injury in Mice" Marine Drugs 20, no. 12: 758. https://doi.org/10.3390/md20120758

APA Style

Wang, J., Fang, Z., Li, Y., Sun, L., Liu, Y., Deng, Q., & Zhong, S. (2022). Ameliorative Effects of Oyster Protein Hydrolysates on Cadmium-Induced Hepatic Injury in Mice. Marine Drugs, 20(12), 758. https://doi.org/10.3390/md20120758

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop